Chinese Adults With Kidney Disease | MicrobiomeTrials← Back to trialsNCT07522099
Chinese Adults With Kidney Disease
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-21Est. Completion: 2028-07-10
Enrollment target: 30 participants Locations- ADARx Clinical Site, Shenzhen, Guangdong, China
- ADARx Clinical Site, Guiyang, Guizhou, China
- ADARx Clinical Site, Zhengzhou, Henan, China
- ADARx Clinical Site, Baotou, Inner Mongolia, China
- ADARx Clinical Site, Wuxi, Jiangsu, China
- ADARx Clinical Site, Yantai, Shandong, China
- ADARx Clinical Site, Beijing, China
- ADARx Clinical Site, Shandong, China
- ADARx Clinical Site, Shanghai, China
- ADARx Clinical Site, Shangxi, China
Other microbiome trials you might be interested in
IgA Nephropathy
This is a phase IIa, multicenter, single-arm, open-label study to evaluate the safety and efficacy of XH-S003 in patient…
Beijing, ChinaCompleted Apr 23, 2026
IgANC3GComplement-mediated Kidney DiseaseIgA Nephropathy (IgAN)IC-MPGN
This Phase 2 study is designed to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of ADX-03…
Doral, United StatesEst. completion Dec 31, 2028